The Current Ratio as of November 2024 (TTM) for Achieve Life Sciences, Inc. (ACHV) is 6.78

According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.78. This represents a change of 75.52% compared to the average of 3.86 of the last 4 quarters.

Achieve Life Sciences, Inc. (ACHV) Historical Current Ratio (quarterly & annually)

How has ACHV Current Ratio performed in the past?

The mean historical Current Ratio of Achieve Life Sciences, Inc. over the last ten years is 4.99. The current 6.78 Current Ratio has changed 13.47% with respect to the historical average. Over the past ten years (40 quarters), ACHV's Current Ratio was at its highest in in the September 2020 quarter at 13.05. The Current Ratio was at its lowest in in the December 2023 quarter at 0.82.

Achieve Life Sciences, Inc. (ACHV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Achieve Life Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Achieve Life Sciences, Inc. (ACHV) Average Current Ratio

How has ACHV Current Ratio performed in the past?

The current Current Ratio of Achieve Life Sciences, Inc. (ACHV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Achieve Life Sciences, Inc. (ACHV) Current Ratio vs. Peers

How is ACHV’s Current Ratio compared to its peers?

Achieve Life Sciences, Inc.’s Current Ratio is less than VectivBio Holding AG (9.14), less than Icosavax, Inc. (18.06), greater than Apellis Pharmaceuticals, Inc. (4.36), less than iTeos Therapeutics, Inc. (14.80), less than TScan Therapeutics, Inc. (9.56), less than Day One Biopharmaceuticals, Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (10.43), greater than X4 Pharmaceuticals, Inc. (4.89), less than Inozyme Pharma, Inc. (7.68), greater than Immix Biopharma, Inc. (3.47), greater than CNS Pharmaceuticals, Inc. (1.82), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Freeline Therapeutics Holdings plc (1.95), less than AVROBIO, Inc. (26.17), less than NextCure, Inc. (9.07), greater than CytomX Therapeutics, Inc. (1.04), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.36), greater than Bolt Biotherapeutics, Inc. (3.16), greater than Coherus BioSciences, Inc. (1.25), less than Gracell Biotechnologies Inc. (7.73),

Build a custom stock screener for Achieve Life Sciences, Inc. (ACHV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achieve Life Sciences, Inc. (ACHV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.